Cargando…

Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab

Detalles Bibliográficos
Autores principales: Wei, Na, Wang, Yini, Wang, Jingshi, Wu, Lin, Wang, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189911/
https://www.ncbi.nlm.nih.gov/pubmed/33420394
http://dx.doi.org/10.1038/s41409-020-01193-7
_version_ 1783705582041038848
author Wei, Na
Wang, Yini
Wang, Jingshi
Wu, Lin
Wang, Zhao
author_facet Wei, Na
Wang, Yini
Wang, Jingshi
Wu, Lin
Wang, Zhao
author_sort Wei, Na
collection PubMed
description
format Online
Article
Text
id pubmed-8189911
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81899112021-06-25 Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab Wei, Na Wang, Yini Wang, Jingshi Wu, Lin Wang, Zhao Bone Marrow Transplant Correspondence Nature Publishing Group UK 2021-01-08 2021 /pmc/articles/PMC8189911/ /pubmed/33420394 http://dx.doi.org/10.1038/s41409-020-01193-7 Text en © The Author(s), under exclusive licence to Springer Nature Limited part of Springer Nature 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Wei, Na
Wang, Yini
Wang, Jingshi
Wu, Lin
Wang, Zhao
Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
title Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
title_full Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
title_fullStr Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
title_full_unstemmed Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
title_short Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
title_sort characteristics of epstein–barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active epstein–barr virus disease: favorable responses to rituximab
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189911/
https://www.ncbi.nlm.nih.gov/pubmed/33420394
http://dx.doi.org/10.1038/s41409-020-01193-7
work_keys_str_mv AT weina characteristicsofepsteinbarrvirusreactivationafterallogeneichaematopoieticstemcelltransplantationinpatientswithchronicactiveepsteinbarrvirusdiseasefavorableresponsestorituximab
AT wangyini characteristicsofepsteinbarrvirusreactivationafterallogeneichaematopoieticstemcelltransplantationinpatientswithchronicactiveepsteinbarrvirusdiseasefavorableresponsestorituximab
AT wangjingshi characteristicsofepsteinbarrvirusreactivationafterallogeneichaematopoieticstemcelltransplantationinpatientswithchronicactiveepsteinbarrvirusdiseasefavorableresponsestorituximab
AT wulin characteristicsofepsteinbarrvirusreactivationafterallogeneichaematopoieticstemcelltransplantationinpatientswithchronicactiveepsteinbarrvirusdiseasefavorableresponsestorituximab
AT wangzhao characteristicsofepsteinbarrvirusreactivationafterallogeneichaematopoieticstemcelltransplantationinpatientswithchronicactiveepsteinbarrvirusdiseasefavorableresponsestorituximab